- Patient perspectives on ipilimumab across the melanoma treatment trajectory. Supportive Care in Cancer. 2017 Academic Article GET IT
Safety and efficacy of durvalumab (MEDI4736), an anti-programmed cell death ligand-1 immune checkpoint inhibitor, in patients with advanced urothelial bladder cancer.
Journal of Clinical Oncology.
Times cited: 154
- Improving quality and addressing the rising costs of cancer care: Two birds, one stone. Journal of Oncology Practice. 2011 Academic Article GET IT